These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Ability of anti-glycoprotein IIb/IIIa agents to dissolve platelet thrombi formed on a collagen surface under blood flow conditions. Goto S, Tamura N, Ishida H. J Am Coll Cardiol; 2004 Jul 21; 44(2):316-23. PubMed ID: 15261925 [Abstract] [Full Text] [Related]
53. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2. Huang TF, Chang CH, Ho PL, Chung CH. Exp Hematol; 2008 Dec 21; 36(12):1704-13. PubMed ID: 18809237 [Abstract] [Full Text] [Related]
54. Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP. Oda A, Yokoyama K, Murata M, Tokuhira M, Nakamura K, Handa M, Watanabe K, Ikeda Y. Thromb Haemost; 1995 Aug 21; 74(2):736-42. PubMed ID: 8585015 [Abstract] [Full Text] [Related]
55. Variable inhibition of high-shear-induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von Willebrand release: a randomized, placebo-controlled, clinical trial. Derhaschnig U, Pachinger C, Jilma B. Am Heart J; 2004 Apr 21; 147(4):E17. PubMed ID: 15077100 [Abstract] [Full Text] [Related]
58. Glycoprotein IIb/IIIa receptor antagonists inhibit the development of platelet procoagulant activity. Pedicord DL, Thomas BE, Mousa SA, Dicker IB. Thromb Res; 1998 Jun 15; 90(6):247-58. PubMed ID: 9700855 [Abstract] [Full Text] [Related]